VEDOLIZUMAB SUBCUTANEOUSLY: REAL-WORLD DATA BEFORE AND AFTER SWITCH IN IBD PATIENTS - A HESSIAN COHORT

Alica Kubesch  ¹     Nina Kruse     Üminye Balaban  ²     Katharina Stratmann     Kathrin Sprinzl     Antje Dienethal     Mate Knabe     Thomas Krause  ³     Stefan Zeuzem     Irina Blumenstein    
¹ University-Hospital Frankfurt, Frankfurt am Main, Germany
² University Hospital, Goethe University, Frankfurt am Main, Germany
³ Gastroenterologie Opernstraße, Kassel, Germany

Session
IBD (Posters)

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)